Association of FTO protein with hyperandrogenism metabolic disturbances in women with polycystic ovary syndrome
References
- Asghari KM, Nejadghaderi SA, Alizadeh M, Sanaie S, Sullman MJ, Kolahi AA, Avery J, Safiri S. Burden of polycystic ovary syndrome in the Middle East and North Africa region, 1990–2019. Sci Rep 12, 7039, 2022.
- Azziz R, Carmina E, Chen ZJ, Dunaif A, Laven JSE, Legro RF, Lizneva D, Natterson-Horowtiz B, Teede HJ, Yildiz BO. Polycystic ovary syndrome. Nature Rev Dis Primers 2, 16057, 2016.
- Balen AH, Tan SL, MacDougall J, Jacobs HS. Miscarriage rates following in-vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin. Hum Reprod 8, 959–964, 1993.
- Berulava T, Rahmann S, Rademacher K, Klein-Hitpass L, Horsthemke B. N6-adenosine methylation in MiRNAs. PloS One 10, e0118438, 2015.
- Huang C, Chen W, Wang X. Studies on the fat mass and obesity-associated (FTO) gene and its impact on obesity-associated diseases. Genes Dis 10, 2351–2365, 2022.
- Conway G, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Franks S, Gambineri A, Kelestimur F, Macut D, Micic D, Pasquali R, Pfeifer M, Pignatelli D, Pugeat M, Yildiz BO; ESE PCOS Special Interest Group. The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. Eur J Endocrinol 171, P1–P29, 2014.
- Fanelli F, Gambineri A, Mezzullo M, Vicennati V, Pelusi C, Pasquali R, Pagotto U. Revisiting hyper-and hypo-androgenism by tandem mass spectrometry. Rev Endocr Metab Disord 14, 185–205, 2013.
- Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Rachel M Freathy RM, Cecilia M Lindgren CM, Perry JRB, Elliott KS, Lango H, Rayner NW, Shields B, Harries LW, Barrett JC, Ellard S, Groves CJ, Knight B, Patch AM, Ness AR, Ebrahim S, Lawlor DA, Ring SM, Ben-ShlomoY, Jarvelin MR, Sovio U, Bennett AJ, Melzer D, Ferrucci L, Loos RJF, Barroso I, Wareham NJ, Karpe F, Owen KR, Cardon LR, Walker M, Hitman GA, Palmer CNA, Doney ASF, Morris AD, Smith GD, Hattersley AT, McCarthy MI. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316, 889–894, 2007.
- Gasmi A, Noor S, Menzel A, Pivina L, Bjorklund G. Obesity and insulin resistance: associations with chronic inflammation, genetic and epigenetic factors. Curr Med Chem 28, 800–826, 2021.
- Gene Ontology and GO Annotations.
https://www.ebi.ac.uk/QuickGO/ . Accessed October, 2019 - Ghosh S, Dhar S, Bhattacharjee S, Bhattacharjee P. Contribution of environmental, genetic and epigenetic factors to obesity-related metabolic syndrome. Nucleus 66, 215–237, 2023.
- Jia G, Yang CG, Yang S, Jian X, Yi C, Zhou Z, He C. Oxidative demethylation of 3-methylthymine and 3-methyluracil in single-stranded DNA and RNA by mouse and human FTO. FEBS Letters 582, 3313–3319, 2008.
- Jing YX, Li HX, Yue F, Li YM, Yu X, He JJ, Zhang XH. N6-methyladenosine demethylase FTO related to hyperandrogenism in PCOS via AKT pathway. Gynecological Endocrinology 39, 2276167, 2023.
- Jurczewska J, Ostrowska J, Chelchowska M, Panczyk M, Rudnicka E, Kucharski M, Smolarczyk R, Szostak-Wegierek D. Abdominal obesity in women with polycystic ovary syndrome and its relationship with diet, physical activity and insulin resistance: a pilot study. Nutrients 15, 3652, 2023.
- Khan MM, Sonkar GK, Alam R, Mehrotra S, Khan MS, Kumar A, Sonkar SK. Validity of Indian Diabetes Risk Score and its association with body mass index and glycosylated hemoglobin for screening of diabetes in and around areas of Lucknow. J Family Med Prim Care 6, 366–373, 2017.
- Kucher AN. The
FTO gene and diseases: The role of genetic polymorphism, epigenetic modifications, and environmental factors. Russian J Gen 56, 1025–1043, 2020. - Lam BC, Koh GC, Chen C, Wong MT, Fallows SJ. Comparison of body mass index (BMI), body adiposity index (BAI), waist circumference (WC), waist-to-hip ratio (WHR) and waist-to-height ratio (WHtR) as predictors of cardiovascular disease risk factors in an adult population in Singapore. PloS One 10, e0122985, 2015.
- Li L, Zang L, Zhang F, Chen J, Shen H, Shu L, Liang F, Feng C, Chen D, Tao H, Xu T, Li Z, Kang Y, Wu H, Tang L, Zhang P, Jin P, Shu Q, Li X. Fat mass and obesity-associated (FTO) protein regulates adult neurogenesis. Hum Mol Genet 26, 2398–2411, 2017.
- Lim SS, Davies MJ, Norman RJ, Moran LJ. Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 18, 618–637, 2012.
- Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, Welt CK; Endocrine Society. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 98, 4565–4592, 2013.
- Loos RJF, Yeo GSH. The genetics of obesity: from discovery to biology. Nat Rev Genet 23, 120–133, 2022.
- Malini NA, Roy George K. Evaluation of different ranges of LH:FSH ratios in polycystic ovarian syndrome (PCOS) - Clinical based case control study. Gen Comp Endocrinol 260, 51–57, 2018.
- Martens FK, Tonk EC, Kers JG, Janssens AC. Small improvement in the area under the receiver operating characteristic curve indicated small changes in predicted risks. J Clin Epidemiol 79, 159–164, 2016.
- Mauer J, Luo X, Blanjoie A, Jiao X, Grozhik AV, Patil DP, Linder B, Pickering BF, Vasseur JJ, Chen Q, Gross SS, Elemento O, Debart F, Kiledjian M, Jaffrey SR. Reversible methylation of m6Am in the 5’ cap controls mRNA stability. Nature 541, 371–375, 2017.
- Morshed MS, Banu H, Akhtar N, Sultana T, Begum A, Zamilla M, Tuqan S, Shah S, Hossain A, Afrine S, Rashid EU. Luteinizing hormone to follicle-stimulating hormone ratio significantly correlates with androgen level and manifestations are more frequent with hyperandrogenemia in women with polycystic ovary syndrome. J Endocrinol Metab 11, 14–21, 2021.
- Mohapatra I, Samantaray SR. BMI and polycystic ovary syndrome: Demographic trends in weight and health. Cureus 16, e55439, 2024.
- Naghshband Z, Malini SS. Association of
FTO gene variant rs9939609 with hyperandrogenemia and fasting glucose levels in South Indian women with polycystic ovarian syndrome. Egypt J Med Hum Genet 23, 79, 2022. - Popovic AM, Hudek Turkovic A, Zuna K, Bacun-Druzina V, Rubelj I, Matovinovic M. FTO gene polymorphisms at the crossroads of metabolic pathways of obesity and epigenetic influences. Food Technol Biotechnol 61, 14–26, 2023.
- Parveen S, Khan S, Ahsan H, Manger PT, Gupta B, Alam R. Fat mass and obesity associated (FTO) gene and polycystic ovary syndrome: Insight into pathogenesis and association with insulin resistance. Hum Nutr Metab 30, 200174, 2022.
- Parveen S, Khan S, Moin S, Nigar A, Alam R. Association of the FTO gene polymorphism rs9939609 in the patho-physiology of polycystic ovary syndrome. Afr J Biol Sci 6, 977–995, 2024a.
- Parveen S, Khan S, Khan MM, Gupta B, Ahmad A, Alam R. Association of lipid profile and obesity in patients with polycystic ovary syndrome. Endocr Regul 58, 83–90, 2024b.
- WHO EC. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 854, 1–452, 1995.
- Sachdeva G, Gainder S, Suri V, Sachdeva N, Chopra S. Obese and non-obese polycystic ovarian syndrome: comparison of clinical, metabolic, hormonal parameters, and their differential response to clomiphene. Indian J Endocrinol Metab 23, 257–262, 2019.
- Singh S, Pal N, Shubham S, Sarma DK, Verma V, Marotta F, Kumar M. Polycystic ovary syndrome: etiology, current management, and future therapeutics. J Clin Med 12, 1454, 2023.
- Somala CS, Sathyapriya S, Bharathkumar N, Anand T, Mathangi DC, Saravanan KM. Therapeutic potential of FTO demethylase in metabolism and disease pathways. Protein J 44, 21–34, 2025.
- The UniProt Consortium. UniProt: the universal protein knowledgebase. Nucleic Acids Res 46, 2699, 2018.
- Yu L, Liu M, Wang Z, Liu T, Liu S, Wang B, Pan B, Dong X, Guo W. Correlation between steroid levels in follicular fluid and hormone synthesis related substances in its exosomes and embryo quality in patients with polycystic ovary syndrome. Reprod Biol Endocrinol 19, 74, 2021.
- Yang J, Chen C. Hormonal changes in PCOS. J Endocrinol 1, 261, 2024.
- Yin D, Li Y, Liao X, Tian D, Xu Y, Zhou C, Liu J, Li S, Zhou J, Nie Y, Liao H. Peng C.
FTO : a critical role in obesity and obesity-related diseases. Br J Nutr 130, 1657–1664, 2023. - Zhao X, Yang Y, Sun BF, Zhao YL, Yang YG. FTO and obesity: mechanisms of association. Curr Diab Rep 14, 486, 2014.
- Zhou L, Han X, Li W, Wang N, Yao L, Zhao Y, Zhang L. N6-methyladenosine demethylase FTO induces the dysfunctions of ovarian granulosa cells by upregulating flotillin 2. Reprod Sci 29, 1305–1315, 2022.
Language: English
Page range: 33 - 41
Published on: Apr 21, 2025
Published by: Slovak Academy of Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 1 times per year
Related subjects:
© 2025 Sadaf Parveen, Saba Khan, Shagufta Moin, Asma Nigar, Mohammad Mustufa Khan, Roshan Alam, published by Slovak Academy of Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.